Home › Hereditary Angioedemas › Ohio
Hereditary Angioedemas clinical trials in Ohio
3 studies for Hereditary Angioedemas are looking for participants at sites in Ohio.
Cities in Ohio
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
- ADARx Clinical Site, Cincinnati
- ADARx Clinical Site, Cleveland
- ADARx Clinical Site, Toledo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06960213Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
- ADARx Clinical Site, Cincinnati
- ADARx Clinical Site, Columbus
- ADARx Clinical Site, Toledo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07428499Donidalorsen Treatment in Children With Hereditary Angioedema
- Ionis Investigative Site, Cincinnati
- Ionis Investigative Site, Cleveland
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 2, 2026 · NCT07298447From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.